Evidence map›Paper›PMID 30042937›Full record

ArticleFrontiers in public health2018

Evidence of Chikungunya Virus Disease in Pakistan Since 2015 With Patients Demonstrating Involvement of the Central Nervous System.

Kelli L Barr, Erum Khan, Joveria Q Farooqi, Kehkashan Imtiaz, Dhani Prakoso, Faisal Malik, John A Lednicky, Maureen T Long

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. The SMARCA4-TMEM47 axis plays an essential role in chikungunya virus RNA replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Development and Application of Treatment for Chikungunya Fever.Research and reports in tropical medicine · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Immunopathogenesis of alphaviruses.Advances in virus research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kelli L BarrDepartment of Comparative, Diagnostic, and Population Medicine, University of Florida, Gainesville, FL, United States.
Erum KhanLaboratory Medicine, Department of Pathology, Aga Khan University, Karachi, Pakistan.
Joveria Q FarooqiLaboratory Medicine, Department of Pathology, Aga Khan University, Karachi, Pakistan.
Kehkashan ImtiazLaboratory Medicine, Department of Pathology, Aga Khan University, Karachi, Pakistan.
Dhani PrakosoDepartment of Comparative, Diagnostic, and Population Medicine, University of Florida, Gainesville, FL, United States.
Faisal MalikLaboratory Medicine, Department of Pathology, Aga Khan University, Karachi, Pakistan.
John A LednickyDepartment of Comparative, Diagnostic, and Population Medicine, University of Florida, Gainesville, FL, United States.
Maureen T LongDepartment of Comparative, Diagnostic, and Population Medicine, University of Florida, Gainesville, FL, United States.
Aga Khan University · PKUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several arboviruses are endemic to and co-circulate in Pakistan. In recent years, Pakistan has observed a rise in arboviral infections. A cross-sectional study for arboviral diseases, which included screening for Chikungunya virus (CHIKV), was initiated in 2015 to determine which pathogens were causing disease in patients presenting to health care services. Exposure to CHIKV was verified via detection of viral nucleic acids or virus-specific IgM with virus-specific neutralizing antibodies. Out of 997 enrolled patients presenting with clinical features suggestive of arboviral disease, 102 patients were positive for CHIKV IgM antibodies and 60 patients were positive for CHIKV nucleic acids or neutralizing antibodies. The data presented here show that CHIKV has been circulating in Pakistan since April of 2015. CHIKV infections were detected in study subjects up to the conclusion of our enrollment period in July 2017. Syndromic and clinical data show that arthralgia was associated with CHIKV as was rash, fever greater than 38°C, and lymphopenia. Neurological symptoms were reported in 49% of CHIKV suspect patients and in 46.6% of confirmed infections. Acute disseminated encephalomyelitis was diagnosed in 5% of confirmed infection and various manifestation of encephalitis diagnosed in an additional 16.6% of patients with confirmed CHIKV infections. CHIKV-exposed patients were just as likely to present with neurological symptoms and encephalitis as patients with West Nile Virus infections but were 4.57 times more likely to have lymphopenia. This proportion of neurological symptoms may be a complicating factor in countries where WNV and/or JEV co-circulate with CHIKV.

Indexed as

arbovirusarthralgiaChikungunyaencephalitisneurologicalneutralizationWest Nile virus

Identifiers

PMID30042937
PMCPMC6048291
OpenAlexW2807874941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.